A tool called iCanDecide prepares patients for making decision about treatment better than static online information, study finds.
IBM Watson for Clinical Trial Matching compares study enrollment criteria with patient data in electronic medical records.
Patients with adherence problems were more likely to take their pills compared with those who received standard care.
Computer-generated diagnoses may mislead patients or parents, research indicates.
Follow-up via mobile app similar to in-person postoperative visits for low-risk ambulatory patients after breast reconstruction.
Nurse-guided and self-directed web-based symptom management interventions (WRITE Symptoms) improved symptom controllability among women with recurrent ovarian cancer.
Real-time reporting and integration of patient symptom reports into clinical practice could benefit patients, but practical obstacles remain.
Lung Cancer Navigator, a mobile, customizable app from LUNGEVITY, helps patients with lung cancer better understand their disease, manage medications, track symptoms, and access support.
An app developed to track posthospitalization progress and activity of patients with breast cancer, adding the information into patients' electronic health records in real time, was presented at SABCS 2016.
Smartphones can motivate patients to stay on track with lifestyle changes.
Social media has become a mainstay of day-to-day life. For patients with cancer, it can be a lifeline to unprecedented support that is unique to their needs.
Using an online decision-support tool led to most men with low-risk prostate cancer choosing active surveillance with less conflict about their decision.
Funding, informatics system, clinical data capture, and European data protection legislation were considered the greatest barriers to effective data sharing.
A Web application called Moovcare that guides follow-up improved survival for patients with advanced lung cancer after receiving initial therapy.
Although Drugs@FDA may be useful for validating trial primary outcomes found on ClinicalTrials.gov, Drugs@FDA lacked information on secondary outcomes and adverse events, including deaths, according to an analysis of data from 100 trials available on both websites.
A new material was developed to soak up chemotherapy drugs after the tumor is treated and before they can circulate throughout the body, potentially limiting the side effects of chemotherapy.
The addition of a patient navigation component to a population-based IT system boosted screening rates for breast cancer, cervical cancer, and colorectal cancer in patients at high risk for nonadherence.
Researchers found tracking symptoms and alerting doctors to problems early led to longer survival for patients with lung cancer.
New research indicates a far greater efficacy in pancreatic cancer drug therapy delivered via implantable device than via IV.
The social media platform Twitter could develop into a useful tool for communicating with the public about cancer clinical trials and for recruiting participants.
Many health care programs have no policies, and may share data with third parties, researchers say.
Families of patients with cancer are more likely to seek information online than support.
Despite increase in point-of-care ultrasound training, stethoscopes remain an important tool for clinicians.
Use of telemedicine allows nurses to accomplish tasks more quickly, increases both collaboration and communication.
A noninvasive technique designed to identify melanin pigment naturally found in melanoma tumor cells shows promise for detecting the spread of skin cancer.
The American Academy of Family Physicians (AAFP) has provided guidelines for physicians wishing to become more active via social media.
A new first-of-its-kind mobile app called Breast Cancer Ally serves as a treatment navigator for patients with breast cancer receiving care.
The new EHR regulations modify Stage 2 of meaningful use program and finalize requirements for Stage 3.
Findings based on small study of childhood cancer survivors with treatment-related deficits shows benefits of computerized cognitive intervention.
The software giant's latest software package offers a mea culpa to users left on the wayside of its previous major system upgrade. This article offers an overview of the program's returning favorites and new features for nurses.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Superior Tolerability, Efficacy With Alectinib in Treatment-Naïve ALK-poistive NSCLC
- Adding Pertuzumab to Adjuvant Therapy Is Beneficial for Some Women with Early Breast Cancer
- Clinical Trials May Benefit Oncology Patients
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Breast Cancer Diagnosis and Nurse Navigation Survey
- Radiotherapy is Essential in Treating Brain Tumors But Associated With Significant Adverse Events
- Prostate-specific PET and CT Imaging Improves Detection of Disease and Patient Care
- Lenvatinib Improves OS, PFS in Radioiodine-Refractory Differentiated Thyroid Cancer in All Older Patients
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Use of Aspirin, NSAIDs Correlates with Improved Overall Survival in Colorectal Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|